Niva Bupa Health Insurance Company Limited has reported no deviation or variation in the utilization of funds raised through its Initial Public Offering (IPO) for the quarter ended September 30, 2025. The company's statement, reviewed by its Audit Committee on November 3, 2025, confirms adherence to the original allocation of funds.

IPO Details and Fund Allocation

Niva Bupa raised gross proceeds of INR 800.00 crores through its public issue, with the allotment date of November 12, 2024. The funds were designated for a specific purpose:

• Objective: Augmentation of capital base to maintain and strengthen solvency levels

Utilization Status

For the quarter ended September 30, 2025:

The company reported that no amount has been utilized from the IPO proceeds during this quarter, maintaining the full allocation of INR 800.00 crores as originally planned.

Compliance and Oversight

The statement on fund utilization was reviewed by the Audit Committee of Niva Bupa in its meeting held on November 3, 2025. This review process ensures transparency and adherence to regulatory requirements regarding the use of IPO funds.

Implications

The absence of any deviation in fund utilization suggests that Niva Bupa is maintaining its commitment to use the IPO proceeds as outlined in its offer documents. This adherence to the stated objectives can be seen as a positive indicator of the company's financial discipline and strategic focus.

Investors and stakeholders can take assurance from this report that the company is proceeding as planned with its capital strengthening initiatives, which are crucial for maintaining robust solvency levels in the insurance sector.

As Niva Bupa continues to manage its IPO funds, future quarters will be important to watch for the actual deployment of these resources towards the stated objective of augmenting its capital base.

Niva Bupa Health Insurance Company Limited , a prominent player in the Indian insurance sector, has announced a significant change in its key managerial personnel. Rajat Sharma, who served as the Company Secretary and Compliance Officer, has tendered his resignation, marking the end of his tenure with the organization.

Resignation Details

The company informed the National Stock Exchange of India Limited (NSE) and BSE Limited about this development through a formal intimation. Here are the key details of the resignation:

Corporate Governance Implications

The resignation of a Company Secretary, who is considered a key managerial personnel, is a significant event from a corporate governance perspective. The Company Secretary plays a crucial role in ensuring compliance with various regulatory requirements and acts as a bridge between the company's board of directors and its stakeholders.

Regulatory Compliance

Niva Bupa Health Insurance Company Limited has adhered to the regulatory requirements by promptly disclosing this information. The intimation was made in accordance with Regulation 30 read with Para A, Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Company's Response

The company's Executive Director & Chief Financial Officer, Vishwanath Mahendra, signed off on the official communication to the stock exchanges. This swift action demonstrates the company's commitment to transparency and regulatory compliance.

As of now, Niva Bupa Health Insurance Company Limited has not announced a successor to Rajat Sharma. The company may provide updates on this matter in due course.

This development comes at a time when the insurance sector in India is experiencing significant growth and regulatory changes.